TRI – Thrombosis Research Institute – Innovators in Thrombosis

Our Mission

At the Thrombosis Research Institute, we are committed to saving millions of lives, preventing long term disability and reducing healthcare costs by delivering pioneering advances in the detection, prevention and treatment of thrombosis.

Get the details

Our Achievements

Our multi-disciplinary programme of laboratory and clinical research has contributed to major advances in venous thromboembolism that have changed clinical practice, and enhanced knowledge and management of atrial fibrillation.

Get the details

Our Research

The Thrombosis Research Institute has been at the centre of global understanding of thrombosis for several decades, producing the highest calibre research into the condition.

Get the details

Click here to scroll down to the page content

Factor XI Inhibitors: A New Horizon in...
Click to view the article

Article source: Cardiology and Therapy
Incidence and risk factors of post-thrombotic syndrome...
Click to view the article

Article source: Thrombosis Research
Optimising prediction of mortality, stroke, and major...
Click to view the article

Article source: BJGP
Meta-analysis on performance of ABC and GARFIELD-AF...
Click to view the article

Article source: ScienceDirect
Anticoagulation and Antiplatelet Therapy for Prevention of...
Click to view the article

Article source: AHA Journals
Detection of Atrial Fibrillation in a Large...
Click to view the article

Article source: AHA Journals
Factor XIa inhibition with asundexian after acute...
Click to view the article

Article source: The Lancet
Vaccination reduces risk for VTE among ambulatory...
Click to view the article

Article source: Hematology/Oncology

TRI in Focus Newsletter: May 2023
Click to view the resource
TRI Services: MedComms & Events
Click to view the resource
TRI Services: Data Sciences
Click to view the resource
TRI ETHIC EnoxaparinKey Paper
Click to view the resource
TRI GARFIELD-AF Co-GDMT OAC Key Paper
Click to view the resource
TRI GARFIELD-AF Key Paper
Click to view the resource
TRI GARFIELD-AF Oral Anticoagulant Key Paper
Click to view the resource
TRI GARFIELD-AF Risk Tool Key Paper
Click to view the resource

Innovators in Thrombosis

Our Mission

Our Achievements

Our Research

Thrombosis News

Factor XI Inhibitors: A New Horizon in...

Incidence and risk factors of post-thrombotic syndrome...

Optimising prediction of mortality, stroke, and major...

Meta-analysis on performance of ABC and GARFIELD-AF...

Anticoagulation and Antiplatelet Therapy for Prevention of...

Detection of Atrial Fibrillation in a Large...

Factor XIa inhibition with asundexian after acute...

Vaccination reduces risk for VTE among ambulatory...

TRI Resources

TRI in Focus Newsletter: May 2023

TRI Services: MedComms & Events

TRI Services: Data Sciences

TRI ETHIC EnoxaparinKey Paper

TRI GARFIELD-AF Co-GDMT OAC Key Paper

TRI GARFIELD-AF Key Paper

TRI GARFIELD-AF Oral Anticoagulant Key Paper

TRI GARFIELD-AF Risk Tool Key Paper

LinkedIn

Quick Links

Introduction to TRI